Storm Therapeutics Ltd has disclosed data from an animal study of a new small molecule inhibitor of an RNA modifying enzyme which showed activity against cancer. The study results were announced on 18 September at a meeting in Cambridge, UK attended by scientists from Europe and the US who are at the forefront of the new science of RNA epigenetics.
RNA epigenetics describes the chemical markers on messenger RNA that carry genetic information from DNA to a cell’s protein-manufacturing factories. When this process is modified by enzymes it can lead to disease.